Prescription-filling rates for key medications in Veterans Affairs patients after coronary artery bypass grafting

Am J Health Syst Pharm. 2004 Jun 15;61(12):1248-52. doi: 10.1093/ajhp/61.12.1248.

Abstract

Purpose: The six-month prescription-filling rates for key secondary-prevention drugs in Department of Veterans Affairs (VA) patients who had undergone coronary artery bypass grafting (CABG) were studied.

Methods: Patient records for elective CABG from April 2000 through March 2002 (divided into four six-month periods) were analyzed. The study population included 8925 CABG-only patients surviving to hospital discharge. For each six-month period and in aggregate, the primary study endpoint was the six-month prescription-filling rate.

Results: Across the four six-month periods, prescription-filling rates increased for all categories of medications studied. There were modest progressive increases for lipid-lowering agents, statins, -blockers, angiotensin-converting-enzyme Inhibitors, and angiotensin-receptor blockers. The antithrombotic-filling rate averaged 88.5%. Filling rates for aspirin were much higher than for aspirin alternatives.

Conclusion: Prescription-filling rates for post-CABG medications in VA facilities were generally high and suggested compliance with guidelines for the prevention of cardiovascular events.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use*
  • Aged
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
  • Anticholesteremic Agents / therapeutic use*
  • Coronary Artery Bypass*
  • Databases, Factual
  • Drug Prescriptions / statistics & numerical data
  • Female
  • Fibrinolytic Agents / therapeutic use*
  • Hospitals, Veterans*
  • Humans
  • Male
  • Middle Aged
  • Myocardial Ischemia / prevention & control*
  • Myocardial Ischemia / surgery
  • Patient Compliance / statistics & numerical data*
  • Pharmacy Service, Hospital
  • Risk Factors
  • United States
  • United States Department of Veterans Affairs

Substances

  • Adrenergic beta-Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Anticholesteremic Agents
  • Fibrinolytic Agents